Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Revenue

Formosa Pharmaceuticals had revenue of 45.42M TWD in the quarter ending March 31, 2026, with 7,546.80% growth. This brings the company's revenue in the last twelve months to 54.32M, up 236.37% year-over-year. In the year 2025, Formosa Pharmaceuticals had annual revenue of 9.50M, down -93.38%.

• Revenue (ttm): 54.32M
• Revenue Growth: +236.37%
• P/S Ratio: 69.20
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.50M	-133.86M	-93.38%
Dec 31, 2024	143.36M	112.18M	359.89%
Dec 31, 2023	31.17M	29.86M	2,270.49%
Dec 31, 2022	1.32M	-27.21M	-95.39%
Dec 31, 2021	28.53M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error